Sydney biotech Immutep has partnered with S&P500 stock LabCorp to develop a diagnostic test helping doctors and oncologists. … Read More
The post Immutep partners with LabCorp to develop immotherapy diagnostic appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.